Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Strong
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Description
Control Bionics Ltd. engages in the manufacture, design, and sale of wireless wearable electromyography (EMG) based augmentative and alternative communication (AAC) technology. It operates through the following segments: Australia, US, International, R&D, and Corporate. The Australia segment is involved with the sales of Trilogy units and components in Australia. The US segment refers to Manufacture and sales of Trilogy units and components in North America. The International segment deals with the activities undertaken to establish viable and additional operating segments. The R&D segment pertains to the Research activities undertaken regarding the Group's products. The Corporate segment offers support, regulatory and infrastructure activities, and elimination entries above the EBITDA line. The company was founded by Peter Shann Ford in 2005 and is headquartered in Sydney, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.04 - 0.1
Trade Value (12mth)
AU$3,290.00
1 week
3.33%
1 month
1.64%
YTD
3.33%
1 year
14.81%
All time high
1.12
EPS 3 yr Growth
-3.40%
EBITDA Margin
-112.60%
Operating Cashflow
-$5m
Free Cash Flow Return
-71.40%
ROIC
-86.00%
Interest Coverage
-107.00
Quick Ratio
1.40
Shares on Issue (Fully Dilluted)
199m
HALO Sector
Technology
Next Company Report Date
20-Aug-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
20 December 24 |
Shortfall placement
×
Shortfall placement |
20 December 24 |
Appendix 2A - shortfall shares
×
Appendix 2A - shortfall shares |
20 December 24 |
Notification regarding unquoted securities - CBL
×
Notification regarding unquoted securities - CBL |
20 December 24 |
Notification regarding unquoted securities - CBL
×
Notification regarding unquoted securities - CBL |
20 December 24 |
Notice Pursuant to Section 708A(5)(e)
×
Notice Pursuant to Section 708A(5)(e) |
17 December 24 |
First Half FY25 Business Update
×
First Half FY25 Business Update |
17 December 24 |
Chair Appointment/Resignation
×
Chair Appointment/Resignation |
17 December 24 |
Final Director's Interest Notice - Hawke
×
Final Director's Interest Notice - Hawke |
16 December 24 |
Expansion into US Sports and Japanese Rehab Markets
×
Expansion into US Sports and Japanese Rehab Markets |
16 December 24 |
Notification of Investor Briefing
×
Notification of Investor Briefing |
28 November 24 |
Change of Director's Interest Notice - Lismore
×
Change of Director's Interest Notice - Lismore |
08 November 24 |
CBL to present at Coffee Microcaps Meeting
×
CBL to present at Coffee Microcaps Meeting |
08 November 24 |
Coffee Microcaps Meeting Presentation
×
Coffee Microcaps Meeting Presentation |
23 October 24 |
Ceasing to be a substantial holder - Chapman
×
Ceasing to be a substantial holder - Chapman |
22 October 24 |
Director Appointment - Straface
×
Director Appointment - Straface |
22 October 24 |
Initial Director's Interest Notice - Straface
×
Initial Director's Interest Notice - Straface |
17 October 24 |
Notice Pursuant to Section 708A(5)(e)
×
Notice Pursuant to Section 708A(5)(e) |
17 October 24 |
Change in substantial holding - Nightingale
×
Change in substantial holding - Nightingale |
17 October 24 |
Change of Director's Interest Notice - Hawke
×
Change of Director's Interest Notice - Hawke |
17 October 24 |
Change of Director's Interest Notice - Lismore
×
Change of Director's Interest Notice - Lismore |
17 October 24 |
Change of Director's Interest Notice - Heard
×
Change of Director's Interest Notice - Heard |
17 October 24 |
Change of Director's Interest Notice - Steele
×
Change of Director's Interest Notice - Steele |
17 October 24 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
16 October 24 |
Application for quotation of securities - CBL
×
Application for quotation of securities - CBL |
16 October 24 |
Appendix 2A - Underwriting shares
×
Appendix 2A - Underwriting shares |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.